Patent · US Expired

Variant of vascular endothelial growth factor

US6506884B1 · kind B1 · utility

2Cited by
3References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 6, 2000
Grant dateJan 14, 2003
Priority date
Expiry dateMar 6, 2020

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K48/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention concerns novel nucleic acid sequences and amino acid sequences of a novel variant of vascular endothelial growth factor (VEGF). The invention further concerns expression vectors and host cells containing said sequences as well as pharmaceutical compositions and detection methods using said sequences.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.